Concepedia

Karen Davis‐Bruno

KD

Statistics

Publications

8

Citations

516

H-Index

8

Active since

1995

Affiliations

United States Food and Drug Administration(Current)

Center for Drug Evaluation and Research

National Center for Toxicological Research

Sanofi (United States)

Environmental Protection Agency

Karen Davis‐Bruno is an author at United States Food and Drug Administration specializing in toxicology, pharmacy, and pharmacology.

Publications per year

1995–2024

8

Publications

8

Expression and Characterization of CD4-IgG <sub>2</sub> , a Novel Heterotetramer That Neutralizes Primary HIV Type 1 Isolates

Graham P. Allaway, Karen Davis‐Bruno, Gary A. Beaudry et al. · AIDS Research and Human Retroviruses · 1995 · 233 citations

, , +13

A Regulatory Perspective on Issues and Approaches in Characterizing Human Metabolites

Karen Davis‐Bruno, Aisar Atrakchi · Chemical Research in Toxicology · 2006 · 70 citations

, , +16

ILSI/HESI maternal toxicity workshop summary: maternal toxicity and its impact on study design and data interpretation

Bruce Beyer, Neil Chernoff, Bengt Danielsson et al. · Birth Defects Research Part B Developmental and Reproductive Toxicology · 2010 · 67 citations

, , +16

Juvenile animal studies: Testing strategies and design

Mark E. Hurtt, G. P. Daston, Karen Davis‐Bruno et al. · Birth Defects Research Part B Developmental and Reproductive Toxicology · 2004 · 37 citations

, , +6

Revisiting the mutagenicity and genotoxicity of N-nitroso propranolol in bacterial and human in vitro assays

Xilin Li, Yuan Le, Ji‐Eun Seo et al. · Regulatory Toxicology and Pharmacology · 2023 · 35 citations · Full text

, , +9

1–5 of 8